UBS has initiated coverage of Unite Group PLC (LSE:UTG), the UK's largest student accommodation operator, with a buy rating and 585p price target, implying 15% upside from current levels, arguing the market is mispricing a cyclical slowdown as permanent demand destruction.
The investment bank contends the stock's 50% discount to net tangible asset value unfairly reflects concerns about structural deterioration in UK student demand when recent weakness is concentrated in postgraduate flows rather than broad-based enrolment decline.
Unite shares have fallen sharply following three consecutive profit warnings, with investors increasingly pessimistic about the combined group following its acquisition of Empiric Student Properties in January 2026.
However, UBS argues that undergraduate applications remain resilient, with domestic and international cohorts both supported by favourable demographics and the continuing financial attractiveness of UK higher education, even as graduate premiums have compressed from pre-pandemic levels.
The combined portfolio benefits from exceptional positioning toward demand strength, with roughly 75-80% of beds aligned to high-tariff universities where application growth accelerated to 5.9% in 2026, versus outright decline at lower-rated institutions.
Supply dynamics are turning decisively supportive, with development viability deteriorating sharply as construction costs have risen 50% since pre-Ukraine war levels while regulatory delays and higher financing costs have squeezed returns to near-zero across most markets.
UBS forecasts 2026/27 represents the trough for occupancy and rental growth, followed by medium-term recovery to 3-4% annual rental growth as net PBSA supply trends toward zero and HMO stock exits the market following implementation of the Renters' Rights Act.
The bank assumes the market prices in structural demand weakness requiring perpetual 2% rental growth with limited recovery, when portfolio quality and supply constraints support faster normalisation once sentiment stabilises.
Valuation metrics support upside, with implied yields at 7.6% screening roughly 100 basis points wide to UBS's sum-of-the-parts fair value estimate of 6.7%, suggesting a material buffer against disposal at discounted pricing.
In morning trading, the shares were up 2% at 521.5p.